La cadena de opciones muestra datos clave de las opciones de acciones de Palisade Bio a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Palisade Bio..

Palisade Bio (NASDAQ:PALI) Bolsa, Cadena de Opciones

Palisade Bio

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

Wall Street ai6

Biotech

Long Ideas

Hedge Funds

Trading Ideas

General

PALI

Point72 invierte en Palisade Bio, empresa biotecnológica de alta volatilidad. Cohen apuesta por terapias intestinales tras duplicar S&amp;P 500.

Steven Cohen duplica al S&amp;P 500: Esta es su próxima apuesta

Palisade Bio Inc

PALISADES GOLDCRP LTD NEW by PALISADES GOLDCORP LTD.

Palisades Goldcorp Ltd

PALIBURG HOLDINGS LTD by PALIBURG HOLDINGS LTD.

Press Releases

Palisade Bio Receives Health Canada Clearance for Phase 1b Trial of PALI-2108 in Fibrostenotic Crohn's Disease (FSCD)

Palisade Bio Reports Positive PALI-2108 Phase 1b Clinical Data

Palisade Bio Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum

Penny Stocks

Palisade Bio Announces Pricing of Upsized $120 Million Underwritten Public Offering of Common Stock

Palisade Bio Announces Closing of Upsized $138 Million Public Offering of Common Stock and Including Full Exercise of Over-Allotment Option

Palisade Bio Announces Cancellation of Special Meeting of Stockholders

Palisade Bio Granted Canadian Patent Covering Composition of Lead Product Candidate PALI-2108

Palisade Bio Announces First Patients Dosed in Phase 1b Study of Oral First-In-Class PDE4 Inhibitor Prodrug, PALI-2108, for the Treatment of Fibrostenotic Crohn's Disease (FSCD)

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Palisade Bio, Inc. (NASDAQ: PALI)

Achieve Life Sciences, Inc. - Common Shares

Achieve Life Sciences

Allogene Therapeutics, Inc. - Common Stock

Allogene Therapeutics

Assembly Biosciences, Inc. - Common Stock

Assembly Biosciences

Black Diamond Therapeutics, Inc. - Common Stock

Black Diamond Therapeutic

Cabaletta Bio

Crescent Biopharma

C4 Therapeutics

Corbus Pharmaceuticals Holdings, Inc. - Common Stock

Corbus Pharmaceuticals

Caribou Biosciences

Fennec Pharmaceuticals Inc. - Common Stock

Fennec Pharmaceuticals

Foghorn Therapeutics

Genfit

Genelux

Heron Therapeutics

Ironwood Pharmaceuticals, Inc. - Class A Common Stock

Ironwood Pharmaceuticals

Pyxis Oncology

Cartesian Therapeutics, Inc. - Common Stock

Cartesian Therapeutics

Sagimet Biosciences Inc. - Series A Common Stock

Sagimet Biosciences

SELLAS Life Sciences Group, Inc. - Common Stock

SELLAS Life Sciences Gr

Protara Therapeutics, Inc. - Common Stock

Protara Therapeutics

Tiziana Life Sciences Ltd - Common Shares

Tiziana Life Sciences

TriSalus Life Sciences, Inc. - Common Stock

TriSalus Life Sciences

Entrada Therapeutics, Inc. - Common Stock

Entrada Therapeutics

Exagen

Zura Bio Limited - Class A Ordinary shares

Comments

Palisade Bio

Palisade Bio (PALI) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL